Abbott has introduced a new campaign featuring actors John Stamos and Jodie Sweetin to encourage adults aged 45 and older to undergo colorectal cancer screening using the Cologuard test. The campaign highlights the importance of early detection, especially as colorectal cancer rates rise among younger adults, and promotes Cologuard as a convenient, noninvasive home screening option. With a high detection rate and FDA approval, the test aims to reduce cancer deaths by making screening accessible and less awkward to discuss. Abbott continues to support colorectal cancer prevention with innovative testing solutions like Cologuard Plus, improving early diagnosis and patient outcomes.
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by rising demand for rapid diagnostics, AI integration, and precision veterinary medicine, alongside i...
The veterinary lab automation market is projected to grow from $1.36 billion in 2026 to $1.9 billion by 2030, with a CAGR of 8.7%. Growth is fueled by increasing demand for rapid diagnostics, AI integration, robotic workflows, and a focus on companio...
